Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$176,459,547
-$2,919,409 QoQ
Shares Held
4,136,417
+11.1% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#8
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRANDES INVESTMENT PARTNERS, LP holds $1,062,449,068 across 8 Drug Manufacturers - General names. SNY ranks #4 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRFS |
Grifols SA
|
37,816,285 | $267,739,296 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,910,947 | $245,556,688 | |
| 3 | PFE |
Pfizer Inc
|
7,634,806 | $183,846,126 | |
| 4 | SNY |
Sanofi
This page
|
4,136,417 | $176,459,547 | |
| 5 | GSK |
GSK plc
|
1,483,198 | $77,749,239 | |
| 6 | JNJ |
Johnson & Johnson
|
276,623 | $70,253,942 | |
| 7 | NVS |
Novartis AG
|
197,593 | $30,966,774 | |
| 8 | OGN |
Organon & Co.
|
729,502 | $9,877,456 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,459,547 | 4,136,417 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $179,378,956 | 3,723,100 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $141,176,384 | 2,913,256 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $133,244,230 | 2,822,971 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $119,990,782 | 2,483,767 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $126,209,044 | 2,275,677 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $105,861,857 | 2,194,938 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $122,109,093 | 2,118,846 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $102,995,732 | 2,122,748 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $95,134,110 | 1,957,492 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $88,050,544 | 1,770,572 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $57,695,988 | 1,075,615 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $55,445,904 | 1,028,681 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $56,418,736 | 1,036,728 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $19,008,629 | 392,497 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,528,410 | 618,843 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,921,441 | 598,070 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $33,755,381 | 657,487 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $34,974,208 | 698,088 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $35,375,918 | 733,788 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $39,006,051 | 740,715 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $36,703,770 | 742,090 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $32,564,531 | 670,190 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $39,206,850 | 781,480 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $51,474,990 | 1,008,325 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $54,610,826 | 1,249,104 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||